Live Breaking News & Updates on Rand Eye Institute Carl Danzig
Stay updated with breaking news from Rand eye institute carl danzig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last week's FDA approval of avacincaptad pegol marked the second approved treatment for geographic atrophy in 2023. Here, 4 retina specialists discuss the complement inhibitor and what it could represent for patients with GA. ....
In an interview at ARVO 2023, Danzig discusses the post-hoc analysis from the GATHER trials, showing that a reduced rate of vision loss in patients receiving avacincaptad pegol was correlated with reduced GA growth. ....